JPWO2022226008A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022226008A5
JPWO2022226008A5 JP2023564141A JP2023564141A JPWO2022226008A5 JP WO2022226008 A5 JPWO2022226008 A5 JP WO2022226008A5 JP 2023564141 A JP2023564141 A JP 2023564141A JP 2023564141 A JP2023564141 A JP 2023564141A JP WO2022226008 A5 JPWO2022226008 A5 JP WO2022226008A5
Authority
JP
Japan
Prior art keywords
lipid
alkyl
pharma
acceptable salt
ceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023564141A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517644A5 (https=
JP2024517644A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/025455 external-priority patent/WO2022226008A2/en
Publication of JP2024517644A publication Critical patent/JP2024517644A/ja
Publication of JP2024517644A5 publication Critical patent/JP2024517644A5/ja
Publication of JPWO2022226008A5 publication Critical patent/JPWO2022226008A5/ja
Pending legal-status Critical Current

Links

JP2023564141A 2021-04-20 2022-04-20 カチオン性脂質及びその組成物 Pending JP2024517644A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163176943P 2021-04-20 2021-04-20
US63/176,943 2021-04-20
US202163217869P 2021-07-02 2021-07-02
US63/217,869 2021-07-02
PCT/US2022/025455 WO2022226008A2 (en) 2021-04-20 2022-04-20 Cationic lipids and compositions thereof

Publications (3)

Publication Number Publication Date
JP2024517644A JP2024517644A (ja) 2024-04-23
JP2024517644A5 JP2024517644A5 (https=) 2025-04-28
JPWO2022226008A5 true JPWO2022226008A5 (https=) 2025-04-28

Family

ID=83723777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564141A Pending JP2024517644A (ja) 2021-04-20 2022-04-20 カチオン性脂質及びその組成物

Country Status (11)

Country Link
US (3) US20240226325A1 (https=)
EP (1) EP4326235A4 (https=)
JP (1) JP2024517644A (https=)
KR (1) KR20230172570A (https=)
AU (1) AU2022262592A1 (https=)
BR (1) BR112023021504A2 (https=)
CA (1) CA3215324A1 (https=)
CO (1) CO2023015501A2 (https=)
IL (1) IL307758A (https=)
MX (1) MX2023012369A (https=)
WO (1) WO2022226008A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230172570A (ko) * 2021-04-20 2023-12-22 제너레이션 바이오 컴퍼니 양이온성 지질 및 이의 조성물
WO2024119103A1 (en) * 2022-12-01 2024-06-06 Generation Bio Co. Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers
JP2025540076A (ja) * 2022-12-01 2025-12-11 ジェネレーション バイオ カンパニー 核酸、イオン化可能な脂質、ステロール、脂質アンカーポリマー、及びヘルパー脂質を含む脂質ナノ粒子、それらの使用
KR20250131271A (ko) * 2022-12-01 2025-09-02 제너레이션 바이오 컴퍼니 신규한 폴리글리세롤-접합된 지질 및 이를 포함하는 지질 나노입자 조성물
EP4683905A1 (en) * 2023-03-22 2026-01-28 Nanovation Therapeutics Inc. Ionizable anionic lipids
CN121532216A (zh) * 2023-04-18 2026-02-13 赛仁生物技术公司 腺相关病毒载体组合物和使用方法
US12311033B2 (en) 2023-05-31 2025-05-27 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
KR102875269B1 (ko) * 2024-06-03 2025-10-24 주식회사 에스엠엘바이오팜 비대칭 구조를 가지는 지질 화합물 및 이를 포함하는 지질 나노 입자 조성물
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG186085A1 (en) * 2010-06-03 2013-01-30 Alnylam Pharmaceuticals Inc Biodegradable lipids for the delivery of active agents
HK1206644A1 (en) * 2012-03-29 2016-01-15 Shire Human Genetic Therapies, Inc. Lipid-derived neutral nanoparticles
AU2013249548A1 (en) * 2012-04-19 2014-11-06 Sirna Therapeutics, Inc. Novel diester and triester based low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
EP4019506A1 (en) * 2013-12-19 2022-06-29 Novartis AG Lipids and lipid compositions for the delivery of active agents
WO2019188867A1 (ja) * 2018-03-27 2019-10-03 日油株式会社 細胞内動態を改善した新規カチオン性脂質
PL3805198T3 (pl) * 2018-06-08 2024-02-12 Fujifilm Corporation Związek, jego sól i cząstki lipidowe
US20210369862A1 (en) * 2018-09-18 2021-12-02 Universiteit Gent Therapeutic nanoparticles and methods of use thereof
MX2023000806A (es) * 2020-07-17 2023-04-11 Generation Bio Co Métodos para encapsular polinucleótidos en tamaños reducidos de nanopartículas lipídicas y formulación novedosa de estos.
KR20230172570A (ko) * 2021-04-20 2023-12-22 제너레이션 바이오 컴퍼니 양이온성 지질 및 이의 조성물

Similar Documents

Publication Publication Date Title
JPWO2021102411A5 (https=)
JPWO2022016089A5 (https=)
JPWO2021195529A5 (https=)
US12252470B2 (en) Lipids and nanoparticle compositions thereof
JP7700101B2 (ja) 閉端ｄｎａおよび切断可能脂質を含む脂質ナノ粒子組成物ならびにそれらの使用方法
JPWO2021046265A5 (https=)
US20240293574A1 (en) Cationic lipids and compositions thereof
KR20230052895A (ko) 폴리뉴클레오타이드를 감소된 크기의 지질 나노입자로 캡슐화하는 방법 및 신규한 지질 나노입자 제형
US20250249123A1 (en) Lipids and compositions thereof
US20230181764A1 (en) Novel lipids and nanoparticle compositions thereof
JPWO2022226008A5 (https=)
JPWO2022266032A5 (https=)
JPWO2022261101A5 (https=)
JPWO2021236479A5 (https=)
RU2023135629A (ru) Катионные липиды и их композиции
RU2023129760A (ru) Катионные липиды и их композиции
JPWO2023287861A5 (https=)
RU2023136316A (ru) КОМПОЗИЦИИ МОДИФИЦИРОВАННЫХ ЛИПИДНЫХ НАНОЧАСТИЦ С ОДНОЦЕПОЧЕЧНЫМ ВАРИАБЕЛЬНЫМ ФРАГМЕНТОМ (scFv) И ИХ ПРИМЕНЕНИЯ